Literature DB >> 22583431

Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase.

Medha Priyadarshini1, Mohammad A Kamal, Nigel H Greig, Marcella Reale, Adel M Abuzenadah, Adeel G A Chaudhary, Ghazi A Damanhouri.   

Abstract

Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two debilitating health disorders afflicting millions worldwide. Recent research has revealed similarities between AD and T2DM. Both these protein conformational disorders are associated with obesity, insulin resistance, inflammation and endoplasmic reticulum stress, en-route initiation and/or stage aggravation. In this mini review we have tried to summarize studies describing obesity, insulin resistance and glucocorticoid imbalance as common patho-mechanisms in T2DM and AD. A reduction in tyrosine hydroxylase (TH) in the brain has been found to occur in Parkinson's disease (PD). AD, T2DM and PD share common risk factors like depression. Thus, whether TH is involved in the 'state of cognitive depression' that is the hallmark of AD and often accompanies PD and T2DM is also explored.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22583431      PMCID: PMC5002347          DOI: 10.2174/187152712800792767

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  108 in total

1.  Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids.

Authors:  Sergio López; Beatriz Bermúdez; Yolanda M Pacheco; José Villar; Rocío Abia; Francisco J G Muriana
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

2.  L-dopa modulates motor cortex excitability in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Alessandro Stefani; Maria Giuseppina Palmieri; Zaira Esposito; Giorgio Bernardi; Giuseppe Sancesario; Mariangela Pierantozzi
Journal:  J Neural Transm (Vienna)       Date:  2008-07-02       Impact factor: 3.575

3.  The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.

Authors:  Andreas Festa; Ken Williams; Ralph D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

4.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

5.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 6.  Cardiovascular risk in the spectrum of type 2 diabetes mellitus.

Authors:  Intekhab Ahmed; Barry J Goldstein
Journal:  Mt Sinai J Med       Date:  2006-09

Review 7.  The influence of different fats and fatty acids on obesity, insulin resistance and inflammation.

Authors:  George A Bray; Jennifer C Lovejoy; Steven R Smith; James P DeLany; Michael Lefevre; Daniel Hwang; Donna H Ryan; David A York
Journal:  J Nutr       Date:  2002-09       Impact factor: 4.798

8.  Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.

Authors:  N Kemppainen; M Laine; M P Laakso; V Kaasinen; K Någren; T Vahlberg; T Kurki; J O Rinne
Journal:  Eur J Neurosci       Date:  2003-07       Impact factor: 3.386

9.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Authors:  Q Y Zhou; C J Quaife; R D Palmiter
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

10.  Impaired insulin secretion increases the risk of Alzheimer disease.

Authors:  E Rönnemaa; B Zethelius; J Sundelöf; J Sundström; M Degerman-Gunnarsson; C Berne; L Lannfelt; L Kilander
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

View more
  21 in total

Review 1.  Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms.

Authors:  Gohar Mushtaq; Jalaluddin A Khan; Taha A Kumosani; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-05-23       Impact factor: 4.219

Review 2.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

3.  In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.

Authors:  Md Rezaul Islam; Aubhishek Zaman; Iffat Jahan; Rajib Chakravorty; Sajib Chakraborty
Journal:  J Young Pharm       Date:  2013-12-15

4.  Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.

Authors:  Qurrat ul Ain; Nigel H Greig; Muhammad S Nawaz; Sajid Rashid; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

Review 5.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

6.  Multigenerational metabolic profiling in the Michigan PBB registry.

Authors:  Douglas I Walker; M Elizabeth Marder; Yukiko Yano; Metrecia Terrell; Yongliang Liang; Dana Boyd Barr; Gary W Miller; Dean P Jones; Michele Marcus; Kurt D Pennell
Journal:  Environ Res       Date:  2019-02-13       Impact factor: 6.498

7.  Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.

Authors:  Ashok Kumar Datusalia; Shyam Sunder Sharma
Journal:  Mol Neurobiol       Date:  2014-01-14       Impact factor: 5.590

8.  Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.

Authors:  Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Deeba Naaz; Shazi Shakil; Adnan Ahmad; Mohd Haneef; Adel M Abuzenadah
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

Review 9.  Maternal high fat diet consumption during the perinatal period programs offspring behavior.

Authors:  Elinor L Sullivan; Elizabeth K Nousen; Katherine A Chamlou
Journal:  Physiol Behav       Date:  2012-10-17

10.  Noggin Along with a Self-Assembling Peptide Nanofiber Containing Long Motif of Laminin Induces Tyrosine Hydroxylase Gene Expression.

Authors:  Shima Tavakol; Sayed Mostafa Modaress Musavi; Behnaz Tavakol; Elham Hoveizi; Jafar Ai; Seyed Mahdi Rezayat
Journal:  Mol Neurobiol       Date:  2016-07-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.